Your browser doesn't support javascript.
loading
ACR Appropriateness Criteria® Diffuse Lung Disease.
Hobbs, Stephen B; Chung, Jonathan H; Walker, Christopher M; Bang, Tami J; Carter, Brett W; Christensen, Jared D; Danoff, Sonye K; Kandathil, Asha; Madan, Rachna; Moore, William H; Shah, Sachin D; Kanne, Jeffrey P.
Afiliação
  • Hobbs SB; Vice-Chair, Informatics and Integrated Clinical Operations and Division Chief, Cardiovascular and Thoracic Radiology, University of Kentucky, Lexington, Kentucky. Electronic address: Stephen.Hobbs@uky.edu.
  • Chung JH; Panel Chair; and Vice-Chair of Quality, and Section Chief, Chest Imaging, Department of Radiology, University of Chicago, Chicago, Illinois.
  • Walker CM; Panel Vice-Chair, University of Kansas Medical Center, Kansas City, Kansas.
  • Bang TJ; Co-Director, Cardiothoracic Imaging Fellowship Committee, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado; Co-Chair, membership committee, NASCI; and Membership committee, ad-hoc online content committee, STR.
  • Carter BW; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Christensen JD; Vice-Chair, Department of Radiology, Duke University Medical Center, Durham, North Carolina; and Chair, ACR Lungs-RADS.
  • Danoff SK; Johns Hopkins Medicine, Baltimore, Maryland; Board of Directors, American Thoracic Society; Senior Medical Advisor, Pulmonary Fibrosis Foundation; and Medical Advisory Board Member, The Myositis Association.
  • Kandathil A; UT Southwestern Medical Center, Dallas, Texas.
  • Madan R; Associate Fellowship Director, Division of Thoracic Imaging, Brigham & Women's Hospital, Boston, Massachusetts.
  • Moore WH; Associate Chair, Clinical Informatics and Chief, Thoracic Imaging, New York University Langone Medical Center, New York, New York.
  • Shah SD; Associate Chief and Medical Information Officer, University of Chicago, Chicago, Illinois; and Primary care physician.
  • Kanne JP; Specialty Chair, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
J Am Coll Radiol ; 18(11S): S320-S329, 2021 11.
Article em En | MEDLINE | ID: mdl-34794591
ABSTRACT
Diffuse lung disease, frequently referred to as interstitial lung disease, encompasses numerous disorders affecting the lung parenchyma. The potential etiologies of diffuse lung disease are broad with several hundred established clinical syndromes and pathologies currently identified. Imaging plays a critical role in diagnosis and follow-up of many of these diseases, although multidisciplinary discussion is the current standard for diagnosis of several DLDs. This document aims to establish guidelines for evaluation of diffuse lung diseases for 1) initial imaging of suspected diffuse lung disease, 2) initial imaging of suspected acute exacerbation or acute deterioration in cases of confirmed diffuse lung disease, and 3) clinically indicated routine follow-up of confirmed diffuse lung disease without acute deterioration. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Pneumopatias Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Pneumopatias Idioma: En Ano de publicação: 2021 Tipo de documento: Article